'Developing a new drug is stumbling in the dark without a map. We are building the GPS'

22 mai 2022 | Sagi Cohen
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
 Site référencé:  Haaretz

Haaretz 

Erdogan threatens new Turkish incursion to create 'safe zones' in north Syria
24/05/2022
Kafr Qasem massacre : Israel makes decision on historic docs. That’s all we can say
24/05/2022
Assassinations won’t stop Iran’s nuclear program
24/05/2022
Tehran assassination : Latest move in secret Israel-Iran war
24/05/2022
16-year-old shot dead during massive brawl in southern Israeli town
24/05/2022
The duality of Shireen Abu Akleh's death
24/05/2022